Overview
Amundsen Davis represented an ophthalmology start-up and its founder in a claim for breach of a non-disclosure agreement and other theories. The claim stemmed from the former CEO’s resignation and formation of a new company seeking to exploit the client’s cutting edge glaucoma treatment and related business information disclosed to the CEO pursuant to NDA.
